Chemotherapy in metastatic male breast cancer

Massimo Lopez, Luigi Di Lauro, Paola Papaldo, Bonaventura Lazzaro

Research output: Contribution to journalArticlepeer-review


14 male patients with metastatic breast cancer received a total of 20 chemotherapeutic trials with 2 basic combination regimens, namely, variants of the Cooper's regimen CMFVP and adriamycin-containing combinations. Overall, a 35% response rate was observed. Our data suggest that cancer of the breast in the male is responsive to the same combinations used in the female, with regimens including adriamycin being probably superior to regimens without it.

Original languageEnglish
Pages (from-to)205-209
Number of pages5
Issue number4
Publication statusPublished - 1985


  • Chemotherapy
  • Male breast cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Chemotherapy in metastatic male breast cancer'. Together they form a unique fingerprint.

Cite this